Neuroblastoma: an ongoing cold front for cancer immunotherapy

Neuroblastoma is the most frequent extracranial childhood tumour but effective treatment with current immunotherapies is challenging due to its immunosuppressive microenvironment. Efforts to date have focused on using immunotherapy to increase tumour immunogenicity and enhance anticancer immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Paul T, Zannoupa, Demetra, Son, Meong Hi, Dahal, Lekh N, Woolley, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668262/
https://www.ncbi.nlm.nih.gov/pubmed/37993280
http://dx.doi.org/10.1136/jitc-2023-007798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668262/
https://www.ncbi.nlm.nih.gov/pubmed/37993280
http://dx.doi.org/10.1136/jitc-2023-007798

Ejemplares similares